Skip to Content

European Society of Gene & Cell Therapy 29th Congress

Oct 11 - Oct 14, 2022

Title: Genetically-modified hematopoietic stem cells as a one-time, systemic treatment for non-hematologic disorders
Type: Oral
Presenter: Bernhard Gentner, SR-TIGET, Milan and Co-founder of Genenta
Time: October 12, 11:10 AM -1:15 PM BST


Edinburgh, UK and virtual